Cargando…
The Value of FENO Measurement for Predicting Treatment Response in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
BACKGROUND: Fractional exhaled nitric oxide (FENO) has been shown to be a marker of airway inflammation in various pulmonary diseases, including chronic obstructive pulmonary disease (COPD). In this study, we assessed the FENO level in patients with acute exacerbations of COPD (AECOPD) and analyzed...
Autores principales: | Zhou, Aiyuan, Zhou, Zijing, Deng, Dingding, Zhao, Yiyang, Duan, Jiaxi, Cheng, Wei, Liu, Cong, Chen, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522317/ https://www.ncbi.nlm.nih.gov/pubmed/33061343 http://dx.doi.org/10.2147/COPD.S263673 |
Ejemplares similares
-
The impact of impaired sleep quality on symptom change and future exacerbation of chronic obstructive pulmonary disease
por: Lin, Ling, et al.
Publicado: (2023) -
Clinical Value of FeNO for Pulmonary Hypertension Diagnosis in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Guo, Wei, et al.
Publicado: (2022) -
The recent advances of phenotypes in acute exacerbations of COPD
por: Zhou, Aiyuan, et al.
Publicado: (2017) -
A comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysis
por: Zhou, Zijing, et al.
Publicado: (2018) -
The role of CAT in evaluating the response to treatment of patients with AECOPD
por: Zhou, Aiyuan, et al.
Publicado: (2018)